Intravenous bisphosphonates for postmenopausal osteoporosis: safety profiles of zoledronic acid and ibandronate in clinical practice.
about
Medication Related Osteonecrosis of the Jaw: 2015 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial SurgeonsStudies of the Effectiveness of Bisphosphonate and Vanadium-Bisphosphonate Compounds In Vitro against Axenic Leishmania tarentolae.Reactive oxygen species and autophagy associated apoptosis and limitation of clonogenic survival induced by zoledronic acid in salivary adenoid cystic carcinoma cell line SACC-83Long-term efficacy, safety, and patient acceptability of ibandronate in the treatment of postmenopausal osteoporosisManagement of osteoporosis of the oldest old.The safety and tolerability profile of therapies for the prevention and treatment of osteoporosis in postmenopausal women.Immune-mediated syndromes following intravenous bisphosphonate therapy.Factors associated with acute-phase response of bisphosphonate-naïve or pretreated women with osteoporosis receiving an intravenous first dose of zoledronate or ibandronate.
P2860
Q26771715-48B17992-5800-430B-A1EA-E99605354C00Q27349075-441E3F76-62BA-43A0-AD8C-2844025AA2BDQ28540022-E30A837D-294F-420E-A972-E4DABE8DFD5BQ34758140-4A011F45-A87C-4FE0-9F39-D0FD3A7E6E81Q38229503-B90330A2-A54E-406B-AD51-070F432496DAQ38611601-C9B50BCB-7E13-4E20-929D-52F618CBD28DQ38752243-1E0B57FF-FC7E-4577-99C9-5D18AFE0A380Q47417160-C6BB3E21-53A0-4BAA-BD60-B3C5D1F62814
P2860
Intravenous bisphosphonates for postmenopausal osteoporosis: safety profiles of zoledronic acid and ibandronate in clinical practice.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Intravenous bisphosphonates fo ...... ndronate in clinical practice.
@ast
Intravenous bisphosphonates fo ...... ndronate in clinical practice.
@en
Intravenous bisphosphonates fo ...... ndronate in clinical practice.
@nl
type
label
Intravenous bisphosphonates fo ...... ndronate in clinical practice.
@ast
Intravenous bisphosphonates fo ...... ndronate in clinical practice.
@en
Intravenous bisphosphonates fo ...... ndronate in clinical practice.
@nl
prefLabel
Intravenous bisphosphonates fo ...... ndronate in clinical practice.
@ast
Intravenous bisphosphonates fo ...... ndronate in clinical practice.
@en
Intravenous bisphosphonates fo ...... ndronate in clinical practice.
@nl
P2093
P2860
P1476
Intravenous bisphosphonates fo ...... ndronate in clinical practice.
@en
P2093
Christian Meier
Claude A Kraenzlin
Marius E Kraenzlin
Patricia Sieber
Patrizia Lardelli
P2860
P304
P356
10.1007/S40261-012-0041-1
P577
2013-02-01T00:00:00Z